3 Life Science Stocks to Buy Now

Three life science stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

This week, TECHNE Corporation (TECH) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). Techne develops, manufactures, and sells biotechnology products and hematology calibrators and controls. For more information, get Portfolio Grader’s complete analysis of TECH stock.

This week, PerkinElmer, Inc.’s (PKI) ratings are up from a C last week to a B. PerkinElmer provides technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services market. With a price of $44.17, it is above the 50-day moving average of $41.24. For more information, get Portfolio Grader’s complete analysis of PKI stock.

This week, Charles River Laboratories International, Inc. (CRL) pushes up from a C to a B rating. Charles River Laboratories is a global provider of services to accelerate the drug discovery and development process. At $57.58, the stock is above the 50-day moving average of $55.03. For more information, get Portfolio Grader’s complete analysis of CRL stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2014/02/3-life-science-stocks-to-buy-now-tech-pki-crl/.

©2021 InvestorPlace Media, LLC